Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Cytokinetics Inc. | 34 | 1 | 2 | 0 | €52.50 | €83.92 | 59.840% |
| Merck & Co. Inc. | 34 | 1 | 5 | 0 | €116.20 | €125.34 | 7.864% |
| Amgen Inc. | 34 | 0 | 11 | 0 | €290.00 | €305.58 | 5.371% |
| Pfizer Inc. | 35 | 4 | 8 | 0 | €25.87 | €40.00 | 54.619% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 10 | 0 | €65.50 | €84.40 | 28.858% |
| Insmed Inc. | 39 | 1 | 10 | 1 | €64.50 | €70.13 | 8.721% |
| AbbVie Inc. | 42 | 0 | 20 | 0 | €153.32 | €176.14 | 14.884% |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | €237.60 | €256.11 | 7.789% |
| Regeneron Pharmaceuticals Inc. | 51 | 1 | 14 | 0 | €981.00 | €1,049.8 | 7.009% |
| Biogen Inc. | 58 | 1 | 8 | 0 | €210.80 | €291.35 | 38.209% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 11 | 0 | €449.00 | €459.80 | 2.405% |
| Eli Lilly Corp. | 79 | 0 | 30 | 0 | €853.00 | €900.00 | 5.510% |